The question seeks to define "Bioavailability" in the context of pharmacology. Bioavailability is a fundamental pharmacokinetic property of drugs. Let's analyze the options to identify the correct definition.
- Option 1: Rate and extent of drug reaching systemic circulation
Bioavailability refers to the fraction (and rate) of an administered drug that reaches the systemic circulation in its unchanged form. It is an essential consideration for the efficacy of oral drugs as only a portion of the drug enters the circulation after being metabolized in the liver or lost in the gastrointestinal tract.
- Option 2: Drug protein binding
This refers to the extent to which drugs bind to serum proteins such as albumin in the blood. It affects the drug distribution phase but is not a direct measure of bioavailability.
- Option 3: Drug metabolism
Drug metabolism is the chemical alteration of a drug by the body (mainly in the liver), transforming it into metabolites. It plays a role in drug elimination rather than directly measuring bioavailability.
- Option 4: Drug excretion
This is the process of eliminating the drug from the body, primarily through the kidneys in urine. Excretion is a pharmacokinetic process impacting drug clearance, but it is separate from bioavailability.
Based on the explanations provided, Option 1 "Rate and extent of drug reaching systemic circulation" is the correct answer. This definition aligns with the pharmacological understanding of bioavailability, which emphasizes both how much and how quickly a drug enters the bloodstream and becomes available for its intended biological effect.